AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Breakthrough Response Observed in Amplia's Pancreatic Cancer Trial
June 16, 2025 12:56 PM AEST| By Team Kalkine MediaHighlights,Amplia Therapeutics reports rare complete response in metastatic pancreatic cancer trial,Narmafotinib shows potential in combination with standard chemotherapy,Fast-track status granted by FDA supports accelerated development,Amplia Therap...
Regulatory Scrutiny Deepens: Monash IVF Faces Pressure Amid Embryo Mix-Up Fallout
June 16, 2025 12:40 PM AEST| By Team Kalkine MediaHighlights,Shares of Monash IVF drop further after regulatory scrutiny,ASX seeks clarity on timing of disclosure,Ongoing concerns,emerge,over embryo transfer protocols,Monash IVF (ASX:MVF) is once again under market pressure as its shares fell sharpl...
EVE Health to Launch Digital Prescription Access for ED and Period Pain Products
June 16, 2025 11:50 AM AEST| By Team Kalkine MediaHighlights,EVE Health and,TeleDocs,partner for digital treatment access,New oral therapies for ED and period pain near launch,Strategic acquisition positions EVE in pharmaceutical market,EVE Health Group’s (ASX:EVE) expansion into regulated pharmaceu...
Courtroom Showdown Looms Over $672M Mayne Pharma Deal as Cosette Seeks Termination
June 16, 2025 11:02 AM AEST| By Team Kalkine MediaHighlights,Court hearing scheduled for 9 September over acquisition dispute,Cosette alleges breaches and seeks breakup fee or damages,Shareholder,vote on takeover set for 18 June,A high-stakes legal showdown is taking shape in the pharmaceutical sect...
Cochlear (ASX:COH) Faces Market Shifts Amid Healthcare Sector Moves
June 13, 2025 07:20 PM AEST| By Team Kalkine MediaHighlights,Cochlear (ASX:COH) updates FY25 within ASX 100 and ASX 200,Healthcare sector movements reflect varied product and service performance,New cochlear implant system launched amid broader market developments,Cochlear Limited (ASX:COH), listed...
Kalkine: Syntara Moves Closer to Breakthrough with Encouraging Myelofibrosis Trial Progress
June 13, 2025 03:59 PM AEST| By Team Kalkine MediaHighlights,Syntara receives fast track status for SNT-5505,Promising results continue in myelofibrosis Phase 2 trial,Final results and pivotal study discussions expected in 2025,Clinical-stage biopharmaceutical company Syntara (ASX:SNT) has reported...
Kalkine: Clarity Pharmaceuticals Surges on Encouraging Prostate Cancer Diagnostic Trial Outcomes
June 13, 2025 12:23 PM AEST| By Team Kalkine MediaHighlights,Shares rose after positive trial update,Cu-SAR-Bombesin shows high diagnostic efficacy,Next steps include registration and broader oncology focus,Clarity Pharmaceuticals (ASX:CU6) experienced a notable market response following the release...
Kalkine: HITIQ (ASX:HIQ) Signs Game-Changing Global Deal with Shock Doctor to Advance Athlete Safety
June 12, 2025 06:27 PM AEST| By Team Kalkine MediaHighlights,HITIQ teams up globally with Shock Doctor,Innovative concussion tech in self-fit mouthguards,New product rollout begins with sports partners in 2025,HITIQ (ASX:HIQ), an innovator in sports technology, has taken a significant leap forward i...
Kalkine: AnteoTech (ASX:ADO) Accelerates Growth with Surge in Life Sciences Revenue and Strategic Global Progress
June 12, 2025 06:09 PM AEST| By Team Kalkine MediaHighlights,AnteoTech (ADO) expects 130% growth in Life Sciences sales for FY2025,Serum Institute places major order for AnteoBind™ valued at A$213,000,Key R&D milestones achieved despite delays in some global projects,AnteoTech (ASX:ADO), a leading n...
Kalkine: EVE Health Group (ASX:EVE) Strengthens Position in Regulated Healthcare with Nextract Acquisition
June 12, 2025 06:06 PM AEST| By Team Kalkine MediaHighlights,EVE completes strategic acquisition of Nextract Pty Ltd,New therapeutic products target major global health markets,Leadership reshuffle supports growth in regulated healthcare,EVE Health Group (ASX:EVE) has officially finalized the acquis...
Kalkine: ASX 200 Biotech Firm Mesoblast Gains Momentum Following FDA Developments
June 12, 2025 04:33 PM AEST| By Team Kalkine MediaHighlights,Mesoblast (ASX:MSB) reports positive discussions with the US FDA on cardiac treatment Revascor,Upcoming FDA meeting scheduled for Ryoncil’s adult trial in graft versus host disease,Progress across two key programs supports sentiment in the...
Kalkine: Monash IVF Faces ASX 200 Scrutiny After Second Embryo Transfer Error
June 12, 2025 02:40 PM AEST| By Team Kalkine MediaHighlights,Monash IVF Group Ltd (ASX:MVF) confirms second embryo transfer issue, prompting market response,Incident occurred at Clayton lab, following a separate Brisbane case disclosed earlier,Independent investigation expanded to include both incid...
Kalkine: Cochlear Launches Smart Implant System as ASX 200 Healthcare Stock Updates FY25 Outlook
June 12, 2025 02:06 PM AEST| By Team Kalkine MediaHighlights,Cochlear Ltd (ASX:COH) introduces Nucleus Nexa System with firmware upgrade functionality,FY25 earnings guidance revised amid slower Services segment performance,Cochlear Ltd (ASX:COH), a key healthcare stock listed on the,ASX 200,,,ASX 10...
Kalkine: Monash IVF (ASX:MVF) Faces Leadership Shakeup Amid Embryo Error Incidents
June 12, 2025 01:50 PM AEST| By Team Kalkine MediaHighlights,CEO steps down following back-to-back embryo mix-ups,Acting CEO appointed as company reassures financial outlook,Renewed calls for national IVF regulation intensify,Monash IVF Group Ltd (ASX:MVF), a member of the ASX300, is under the spotl...
Kalkine: Monash IVF (ASX:MVF) Rises as CEO Steps Down Amid Second Embryo Mix-Up
June 12, 2025 01:46 PM AEST| By Team Kalkine MediaHighlights,Monash IVF CEO exits following second embryo transfer error,Shares surge,nearly 8%,after leadership change,Public demand rises for national IVF regulation,Shares of fertility services provider Monash IVF (ASX:MVF) surged following the resi...
Kalkine: Cochlear (ASX:COH) Shares Stabilise Amid Guidance Update and Product Launch in ASX300
June 12, 2025 12:34 PM AEST| By Team Kalkine MediaHighlights,Cochlear updates FY guidance; stock recovers early losses,New product launch aims to lift future revenue streams,ASX300 spotlight: Innovation counters market slowdown,Cochlear (ASX:COH), a key player in the hearing implant space and a cons...
Kalkine: Cettire (ASX:CTT) Shares Plunge Amid Weak Trading Update; ASX300 Firm Faces Steep Cash Burn
June 12, 2025 12:30 PM AEST| By Team Kalkine MediaHighlights,Cettire's,Q4 performance fell short of EBITDA expectations,Revenue and cash levels declined sharply in April and May,Concerns grow over potential equity raise to restore capital buffer,Luxury online fashion retailer,Cettire (ASX:CTT),saw a...
Kalkine : ASX 200 Stock Monash IVF Rebounds After Embryo Mix-Up Concerns
June 11, 2025 05:37 PM AEST| By Team Kalkine MediaHighlights,Monash IVF shares regain ground after a sharp decline on Tuesday,Macquarie labels the share price fall as an overreaction,Ongoing support for IVF sector expected despite operational errors,Monash IVF Group Ltd (ASX:MVF), listed on the,ASX...
Kalkine: ASX 200 Biotech Stock CU6 Surges on Promising Trial Data
June 11, 2025 04:17 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals Ltd (ASX:CU6) reported successful Phase II trial results for neuroendocrine tumour diagnostics,Company advancing targeted copper theranostics for cancer using SAR Technology Platform,ASX 200 index gains amid renewed...
Kalkine: Noxopharm's Sofra™ Platform Gains Momentum with BioRay Study in ASX300 Biotech Space
June 11, 2025 03:30 PM AEST| By Team Kalkine MediaHighlights,Noxopharm’s Sofra™ tech validated through BioRay testing,Promising inflammation-fighting results from oligonucleotide platform,Collaboration boosts Sofra’s potential as versatile ASX300 biotech innovation,Noxopharm Limited (ASX:NOX), a cli...
Advertise your brand on Kalkine Media